Skip to main content
Journal cover image

Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Publication ,  Journal Article
Gao, Y-J; Ji, R-R
Published in: Pharmacol Ther
April 2010

Millions of people worldwide suffer from neuropathic pain as a result of damage to or dysfunction of the nervous system under various disease conditions. Development of effective therapeutic strategies requires a better understanding of molecular and cellular mechanisms underlying the pathogenesis of neuropathic pain. It has been increasingly recognized that spinal cord glial cells such as microglia and astrocytes play a critical role in the induction and maintenance of neuropathic pain by releasing powerful neuromodulators such as proinflammatory cytokines and chemokines. Recent evidence reveals chemokines as new players in pain control. In this article, we review evidence for chemokine modulation of pain via neuronal-glial interactions by focusing on the central role of two chemokines, CX3CL1 (fractalkine) and CCL2 (MCP-1), because they differentially regulate neuronal-glial interactions. Release of CX3CL1 from neurons is ideal to mediate neuronal-to-microglial signaling, since the sole receptor of this chemokine, CX3CR1, is expressed in spinal microglia and activation of the receptor leads to phosphorylation of p38 MAP kinase in microglia. Although CCL2 was implicated in neuronal-to-microglial signaling, a recent study shows a novel role of CCL2 in astroglial-to-neuronal signaling after nerve injury. In particular, CCL2 rapidly induces central sensitization by increasing the activity of NMDA receptors in dorsal horn neurons. Insights into the role of chemokines in neuronal-glial interactions after nerve injury will identify new targets for therapeutic intervention of neuropathic pain.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pharmacol Ther

DOI

EISSN

1879-016X

Publication Date

April 2010

Volume

126

Issue

1

Start / End Page

56 / 68

Location

England

Related Subject Headings

  • Receptors, HIV
  • Receptors, Cytokine
  • Pharmacology & Pharmacy
  • Neurons
  • Neuronal Plasticity
  • Neuroglia
  • Neuralgia
  • Nerve Degeneration
  • Models, Neurological
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gao, Y.-J., & Ji, R.-R. (2010). Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther, 126(1), 56–68. https://doi.org/10.1016/j.pharmthera.2010.01.002
Gao, Yong-Jing, and Ru-Rong Ji. “Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.Pharmacol Ther 126, no. 1 (April 2010): 56–68. https://doi.org/10.1016/j.pharmthera.2010.01.002.
Gao Y-J, Ji R-R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010 Apr;126(1):56–68.
Gao, Yong-Jing, and Ru-Rong Ji. “Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.Pharmacol Ther, vol. 126, no. 1, Apr. 2010, pp. 56–68. Pubmed, doi:10.1016/j.pharmthera.2010.01.002.
Gao Y-J, Ji R-R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010 Apr;126(1):56–68.
Journal cover image

Published In

Pharmacol Ther

DOI

EISSN

1879-016X

Publication Date

April 2010

Volume

126

Issue

1

Start / End Page

56 / 68

Location

England

Related Subject Headings

  • Receptors, HIV
  • Receptors, Cytokine
  • Pharmacology & Pharmacy
  • Neurons
  • Neuronal Plasticity
  • Neuroglia
  • Neuralgia
  • Nerve Degeneration
  • Models, Neurological
  • Humans